- Home
- GENC vs AQST Comparison
GENC vs AQST Comparison
Compare GENC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- AQST
- Stock Information
- Founded
- GENC 1894
- AQST 2004
- Country
- GENC United States
- AQST United States
- Employees
- GENC 317
- AQST N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GENC Industrials
- AQST Health Care
- Exchange
- GENC Nasdaq
- AQST Nasdaq
- Market Cap
- GENC 224.6M
- AQST 285.4M
- IPO Year
- GENC N/A
- AQST 2018
- Fundamental
- Price
- GENC $15.10
- AQST $2.97
- Analyst Decision
- GENC
- AQST Strong Buy
- Analyst Count
- GENC 0
- AQST 8
- Target Price
- GENC N/A
- AQST $10.38
- AVG Volume (30 Days)
- GENC 24.3K
- AQST 1.4M
- Earning Date
- GENC 02-11-2025
- AQST 03-04-2025
- Dividend Yield
- GENC N/A
- AQST N/A
- EPS Growth
- GENC 35.02
- AQST N/A
- EPS
- GENC 1.11
- AQST N/A
- Revenue
- GENC $113,116,000.00
- AQST $58,900,000.00
- Revenue This Year
- GENC N/A
- AQST $18.44
- Revenue Next Year
- GENC N/A
- AQST N/A
- P/E Ratio
- GENC $13.37
- AQST N/A
- Revenue Growth
- GENC 5.44
- AQST 22.56
- 52 Week Low
- GENC $14.75
- AQST $2.24
- 52 Week High
- GENC $24.88
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- GENC 30.47
- AQST 34.27
- Support Level
- GENC $15.29
- AQST $2.87
- Resistance Level
- GENC $16.33
- AQST $3.17
- Average True Range (ATR)
- GENC 0.63
- AQST 0.14
- MACD
- GENC 0.05
- AQST 0.02
- Stochastic Oscillator
- GENC 0.00
- AQST 9.30
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.